Cite

HARVARD Citation

    Holmer, A. et al. (n.d.). Serum Biomarkers Are Associated With Endoscopic and Clinical Outcomes in Crohn's Disease Patients Receiving Vedolizumab Therapy. American journal of gastroenterology. p. . [Online]. 
  
Back to record